‘Tropicana’ rose plants (Rosa hybrida L.) were exposed to increasing periods of high intensity light (640 W/m2) beginning immediately after flower removal, in the fall and winter of 1975 and spring and summer of 1976. Flowers were also removed from ‘Forever Yours’ and ‘Cara Mia’ plants in the summer of 1976 and shoot length, stem diameter and bud diameter were evaluated as morphological indicators of blind shoot development. Plants were transferred to a growth chamber (300 W/m2) following the high intensity lighting treatment. Plants grown in the growth chamber without supplemental lighting had the highest percentage of blind shoots. Maximum blindness occurred during the winter months regardless of lighting treatments. Blind shoot production decreased with increased duration of supplemental lighting. Shoot length proved to be an effective indicator of blind shoots as early as 10 days following lateral bud initiation on all cultivars. The value of bud diameter and stem diameter as indicators of blindness was dependent on cultivars.
Fresh, unfixed meristems of rose (Rosa hybrida L.) were viewed in the scanning electron microscope to determine the morphological differences and organogenesis of flowering and blind shoots. Gluteraldehyde fixed, ethanol dehydrated and critical point dried tissue was severely desiccated with individual cell walls becoming concave. Fresh tissue remained turgid for at least 10 min in the microscope. Visible signs of flower initiation were evidenced by the presence of sepal primordia followed by differentiation of petals, anthers and stigma. No evidence of flower initiation was observed in the blind shoot.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.